Arterial stiffness, hypertension, and rational use of nebivolol.
about
Quantification of aortic stiffness using magnetic resonance elastography: Measurement reproducibility, pulse wave velocity comparison, changes over cardiac cycle, and relationship with ageQuantification of aortic stiffness using MR elastography and its comparison to MRI-based pulse wave velocityReference values of brachial-ankle pulse wave velocity according to age and blood pressure in a central Asia populationArterial stiffness and cardiovascular therapyModifiable risk factors for increased arterial stiffness in outpatient nephrologyEffect of beta-1-blocker, nebivolol, on central aortic pressure and arterial stiffness in patients with essential hypertension.The reverse remodeling of the aorta in patients after renal transplantation - the value of aortic stiffness index: prospective echocardiographic study.Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.Increased vascular smooth muscle cell stiffness: a novel mechanism for aortic stiffness in hypertensionNovel therapeutic strategies targeting vascular endothelium in essential hypertension.Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers.Arterial stiffness: from physiology to clinical implications.Vasodilating versus first-generation β-blockers for cardiovascular protection.Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics.β-blockers: a review of their pharmacological and physiological diversity in hypertension.Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients.Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol.Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.Quantification and comparison of 4D-flow MRI-derived wall shear stress and MRE-derived wall stiffness of the abdominal aorta.Silencing of activin receptor-like kinase 7 alleviates aortic stiffness in type 2 diabetic rats.The effect of low-dose carvedilol, nebivolol, and metoprolol on central arterial pressure and its determinants: a randomized clinical trial.Singular and combined effects of nebivolol and lifestyle modification on large artery stiffness in hypertensive adults.Cardiovascular magnetic resonance elastography: A review.Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study.Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women.Improvement of arterial stiffness by reducing oxidative stress damage in elderly hypertensive patients after 6 months of atorvastatin therapy.Reference value of brachial-ankle pulse wave velocity for the eastern Chinese population and potential influencing factors.MR elastography as a method to estimate aortic stiffness and its comparison against MR based pulse wave velocity measurement.Quantification of aortic stiffness across the cardiac cycle using magnetic resonance elastography.
P2860
Q30357772-CC757056-B4E9-42E9-8762-6BC4D13ED79AQ30419384-3B9CC375-8F69-4CC7-9138-8789B66DCBE7Q33558616-5B06DC30-9458-4024-86EB-97FC58A2E922Q34079790-C84C618E-1C9F-4F0E-98AF-EA1663F2DC34Q35448958-7533D6E8-DDC3-4B36-A476-B010C1C51176Q36021055-A9944BFC-79D9-48C5-B68B-32231A6D3D31Q36257881-1FBD57A2-B01F-41C2-84CD-966256DCA00BQ37221225-B0D5C47F-9DDE-47AE-94FF-6896B94ADDB8Q37327436-296B01AD-0D13-4D37-8DFF-AA12EA16D2A3Q37342081-DCCD7972-3A99-430E-BF78-C54BA271F77EQ37798006-03B863DD-8ADD-49AB-9827-DFCB7467A2FCQ37826799-0627BBB0-1379-4F1E-9A97-224D1744BD2FQ37879653-A8615C93-56FD-46D4-8D03-5973F86CCC13Q37995858-280DCA93-CE32-40CF-9961-22138F6E5C6BQ38006018-2562F1C6-2F08-45E3-A0FC-519A8261C50BQ38200949-D42AEEB2-827F-42D6-A2D7-C5744FDC0C63Q38850818-45D76407-9BEF-48E8-8A45-71CF216F16FFQ38913816-6F8AFEC5-57ED-4F96-A931-FB926E72B11DQ39157832-F8844C95-5459-4E68-9A03-05699C0A936CQ39414085-A0FB078F-F80B-45C8-9B1D-81FB045658F9Q42175254-F0B1FF38-BA95-4ECA-A282-AD360062E887Q44501331-D11C8A07-472B-4B02-9FB7-093AD70DE898Q44990862-A028DA57-4C7F-4429-9724-8BB99B62B0C7Q47295939-BD2CED69-0D0B-4741-8FA4-2CDD7F309A2BQ50653681-E464F582-6105-4AB5-9EC0-3AB787D49B84Q51374403-CE8FCE35-D37B-4A30-BDE7-27EF841D57F6Q51393107-5D9FB0DB-9FB1-4E38-9E8D-4D381E3A0B83Q51421000-18E16F93-CC05-4D38-B5EB-07CACB8E2A5BQ55177099-9BED0A65-7626-40F9-BD59-4A571B401344Q55537499-999BD869-2B4A-44F3-8194-C95DBE810423
P2860
Arterial stiffness, hypertension, and rational use of nebivolol.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Arterial stiffness, hypertension, and rational use of nebivolol.
@en
Arterial stiffness, hypertension, and rational use of nebivolol.
@nl
type
label
Arterial stiffness, hypertension, and rational use of nebivolol.
@en
Arterial stiffness, hypertension, and rational use of nebivolol.
@nl
prefLabel
Arterial stiffness, hypertension, and rational use of nebivolol.
@en
Arterial stiffness, hypertension, and rational use of nebivolol.
@nl
P2093
P2860
P921
P356
P1476
Arterial stiffness, hypertension, and rational use of nebivolol.
@en
P2093
Damiano Rizzoni
Enrico Agabiti-Rosei
Enzo Porteri
P2860
P304
P356
10.2147/VHRM.S3056
P407
P577
2009-01-01T00:00:00Z